Liraglutide treatment reduced interleukin-6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy
利拉鲁肽治疗可降低1型糖尿病成人患者的白细胞介素-6水平,但并未改善已确诊的自主神经病变或多发性神经病变。
期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.14063
Brock, Christina; Hansen, Christian Stevns; Karmisholt, Jesper; Møller, Holger Jon; Juhl, Anne; Farmer, Adam Donald; Drewes, Asbjørn Mohr; Riahi, Sam; Lervang, Hans Henrik; Jakobsen, Poul Erik; Brock, Birgitte